Patent Assignment
Reel/Frame 071163/0761
Change of Name
Recorded: 2025-05-02
Pages: 5
Assignor
ADARE DEVELOPMENT I, L.P.
Executed: 2019-11-25
Assignee
ADARE PHARMACEUTICALS US, LP
1200 LENOX DRIVE, SUITE 100, LAWRENCEVILLE, NEW JERSEY, 08648
Covered Property
(1)
Orally Administered Corticosteroid Compositions
Application:
19/170,231 →
Publication:
US 2026/0021041
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 2, 2025
From: PERRETT, STEPHEN; COHEN, FREDRIC JAY; VENKATESH, GOPI
To: EURAND, INC.
Reel/Frame 071013/0405 →
Assignment of Assignor's Interest
May 2, 2025
From: ADARE PHARMACEUTICALS, INC.
To: ADARE DEVELOPMENT, I L.P.
Reel/Frame 071013/0449 →
Change of Name
May 2, 2025
From: EURAND, INCORPORATED
To: APTALIS PHARMATECH, INC.
Reel/Frame 071163/0714 →
Change of Name
May 2, 2025
From: APTALIS PHARMATECH, INC.
To: ADARE PHARMACEUTICALS, INC.
Reel/Frame 071163/0725 →
Change of Name
May 2, 2025
From: ADARE PHARMACEUTICALS US, L.P.
To: ELLODI PHARMACEUTICALS, L.P.
Reel/Frame 071163/0777 →